CARE revises ratings of Suven Life Sciences’ bank facilities

08 Sep 2015 Evaluate

Credit rating agency, CARE has revised rating of Suven Life Sciences’ long term bank facilities worth Rs 102.97 crore to ‘A-’ from ‘BBB+’. The rating agency has also revised rating of company’s short term bank facilities worth Rs 22.50 crore to ‘A2+’ from ‘A3+’.

The revision in the ratings assigned to the bank facilities of the company’s takes into account the equity infusion of around Rs 200 crore primarily for the purpose of funding the progression of the company’s New Chemical Entities (NCE) pipeline which has led to improved liquidity position and improved capital structure as on March 31, 2015.

Suven Life Science is a biopharmaceutical company focused on discovering, developing and commercializing novel pharmaceutical products, which are first in class or best in class CNS therapies through the use of GPCR targets.

Suven Life Sciences Share Price

168.05 5.00 (3.07%)
30-Dec-2025 09:58 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1716.25
Dr. Reddys Lab 1271.35
Cipla 1488.05
Zydus Lifesciences 899.90
Lupin 2082.90
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×